Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Alessandro Russo's publication output changed over time?
ScholarIQpublication output · 2015–2025
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2025.
1
2
1
3
2
1
1
2015201720192020202120222025
What are the most-cited papers on Alessandro Russo?
ScholarIQmost cited works
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, Luigia Stefania Stucci, Alessandro Russo, Enrica T. Tanda, Francesco Spagnolo, Francesca Rastelli, Renato Bisonni, Daniele Santini, Marco Russano, Cecilia Anesi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Mario Occhipinti, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Claudia Bareggi, Olga Nigro, Alessandro Tuzi, Michele De Tursi, Nicola Petragnani, Laura Pala, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Barbara Di Cocco, Domenico Mallardo, Maria Grazia Vitale, David J. Pinato, Giampiero Porzio, Corrado Ficorella, Paolo A. Ascierto
S2754803477. 2020272 CitationsOPEN ACCESS
RET fusions in solid tumors
Andrew Y. Li, Michael G. McCusker, Alessandro Russo, Katherine A. Scilla, Allison Gittens, Katherine E. Arensmeyer, Ranee Mehra, Vincenzo Adamo, Christian Rolfo
S49831067. 2019256 Citations
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer
Gianluca Tomasello, Fausto Petrelli, Michele Ghidini, Alessandro Russo, Rodolfo Passalacqua, Sandro Barni
JAMA Oncology. 2017206 CitationsOPEN ACCESS
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
Alex Friedlaender, Vivek Subbiah, Alessandro Russo, Giuseppe Luigi Banna, Umberto Malapelle, Christian Rolfo, Alfredo Addeo
S41981144. 2021199 Citations
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
Alessandro Russo, Tindara Franchina, Giuseppina Rosaria Rita Ricciardi, Antonio Picone, Giuseppa Ferraro, Mariangela Zanghì, Giuseppe Toscano, Antonio Giordano, Vincenzo Adamo
Oncotarget. 2015174 CitationsOPEN ACCESS
Related on ScholarIQ
Humanitas University
Institution
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Paper
RET fusions in solid tumors
Paper
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer
Paper
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
Paper
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
Paper